Found: 25
Select item for more details and to access through your institution.
The role of phosphodiesterase 4 in the pathophysiology of atopic dermatitis and the perspective for its inhibition.
- Published in:
- Experimental Dermatology, 2019, v. 28, n. 1, p. 3, doi. 10.1111/exd.13808
- By:
- Publication type:
- Article
Evaluation Of Oral Health Status, Salivary Characteristics And Dental Caries Experience In Down's Syndrome Children.
- Published in:
- National Journal of Integrated Research in Medicine, 2013, v. 4, n. 6, p. 59
- By:
- Publication type:
- Article
Pharmacokinetic Profile of Brepocitinib with Topical Administration in Atopic Dermatitis and Psoriasis Populations: Strategy to Inform Clinical Trial Design in Adult and Pediatric Populations.
- Published in:
- Pharmaceutical Research, 2024, v. 41, n. 4, p. 623, doi. 10.1007/s11095-024-03654-w
- By:
- Publication type:
- Article
Utilization of Rosuvastatin and Endogenous Biomarkers in Evaluating the Impact of Ritlecitinib on BCRP, OATP1B1, and OAT3 Transporter Activity.
- Published in:
- Pharmaceutical Research, 2023, v. 40, n. 11, p. 2639, doi. 10.1007/s11095-023-03564-3
- By:
- Publication type:
- Article
Treatment of plaque psoriasis with an ointment formulation of the Janus kinase inhibitor, tofacitinib: a Phase 2b randomized clinical trial.
- Published in:
- BMC Dermatology, 2016, v. 16, p. 1, doi. 10.1186/s12895-016-0051-4
- By:
- Publication type:
- Article
Moving Beyond Boundaries: Utilization of Longitudinal Exposure–Response Model for Bounded Outcome Score to Inform Decision Making in the Accelerated Drug Development Paradigm.
- Published in:
- Clinical Pharmacokinetics, 2024, v. 63, n. 3, p. 381, doi. 10.1007/s40262-024-01347-6
- By:
- Publication type:
- Article
Evolution of Ritlecitinib Population Pharmacokinetic Models During Clinical Drug Development.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 12, p. 1765, doi. 10.1007/s40262-023-01318-3
- By:
- Publication type:
- Article
Delivery Strategies to Improve In Vivo Stability of Immunogenic Peptide PADRE.
- Published in:
- Current Trends in Biotechnology & Pharmacy, 2012, v. 6, n. 2, p. 166
- By:
- Publication type:
- Article
Safety, Effectiveness, and Pharmacokinetics of Crisaborole in Infants Aged 3 to < 24 Months with Mild-to-Moderate Atopic Dermatitis: A Phase IV Open-Label Study (CrisADe CARE 1).
- Published in:
- American Journal of Clinical Dermatology, 2020, v. 21, n. 2, p. 275, doi. 10.1007/s40257-020-00510-6
- By:
- Publication type:
- Article
Evaluation of the Impact of Ritlecitinib on Organic Cation Transporters Using Sumatriptan and Biomarkers as Probes.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, n. 7, p. 784, doi. 10.1002/jcph.2215
- By:
- Publication type:
- Article
Predictors of Systemic Exposure to Topical Crisaborole: A Nonlinear Regression Analysis.
- Published in:
- Journal of Clinical Pharmacology, 2020, v. 60, n. 10, p. 1344, doi. 10.1002/jcph.1624
- By:
- Publication type:
- Article
Systemic Tofacitinib Concentrations in Adult Patients With Atopic Dermatitis Treated With 2% Tofacitinib Ointment and Application to Pediatric Study Planning.
- Published in:
- Journal of Clinical Pharmacology, 2019, v. 59, n. 6, p. 811, doi. 10.1002/jcph.1360
- By:
- Publication type:
- Article
FDA Public Meeting Report on "Drug Interactions With Hormonal Contraceptives: Public Health and Drug Development Implications".
- Published in:
- Journal of Clinical Pharmacology, 2018, v. 58, n. 12, p. 1655, doi. 10.1002/jcph.1285
- By:
- Publication type:
- Article
Simulating Healthy Participant Pharmacokinetics for Renal and Hepatic Impairment Studies: Retrospective Assessment of the Approach.
- Published in:
- AAPS Journal, 2024, v. 26, n. 4, p. 1, doi. 10.1208/s12248-024-00928-4
- By:
- Publication type:
- Article
Correction: Virtual Bioequivalence Assessment of Ritlecitinib Capsules with Incorporation of Observed Clinical Variability Using a Physiologically Based Pharmacokinetic Model.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Virtual Bioequivalence Assessment of Ritlecitinib Capsules with Incorporation of Observed Clinical Variability Using a Physiologically Based Pharmacokinetic Model.
- Published in:
- AAPS Journal, 2024, v. 26, n. 1, p. 1, doi. 10.1208/s12248-024-00888-9
- By:
- Publication type:
- Article
Leveraging Prior Healthy Participant Pharmacokinetic Data to Evaluate the Impact of Renal and Hepatic Impairment on Ritlecitinib Pharmacokinetics.
- Published in:
- AAPS Journal, 2023, v. 25, n. 3, p. 1, doi. 10.1208/s12248-023-00792-8
- By:
- Publication type:
- Article
Biopharmaceutic Planning in Pediatric Drug Development.
- Published in:
- AAPS Journal, 2012, v. 14, n. 3, p. 519, doi. 10.1208/s12248-012-9364-3
- By:
- Publication type:
- Article
Summary Workshop Report: Facilitating Oral Product Development and Reducing Regulatory Burden Through Novel Approaches to Assess Bioavailability/Bioequivalence.
- Published in:
- 2012
- By:
- Publication type:
- Report
Interaction of dicaproyl phosphatidylserine with recombinant factor VIII and its impact on immunogenicity.
- Published in:
- AAPS Journal, 2006, v. 8, n. 2, p. E362, doi. 10.1007/BF02854907
- By:
- Publication type:
- Article
Evaluation of the effect of ritlecitinib on the pharmacokinetics of caffeine in healthy participants.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2208, doi. 10.1111/bcp.15695
- By:
- Publication type:
- Article
A phase 2 study of filibuvir in combination with pegylated IFN alfa and ribavirin for chronic HCV.
- Published in:
- Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2014, v. 13, n. 4, p. 364, doi. 10.1016/s1665-2681(19)30843-9
- By:
- Publication type:
- Article
Phase 1 study of crisaborole in Japanese healthy volunteers and patients with atopic dermatitis.
- Published in:
- Journal of Dermatology, 2020, v. 47, n. 1, p. 25, doi. 10.1111/1346-8138.15123
- By:
- Publication type:
- Article
Population PK and PD Analysis of Domagrozumab in Pediatric Patients with Duchenne Muscular Dystrophy.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 6, p. 1291, doi. 10.1002/cpt.2747
- By:
- Publication type:
- Article
Industrial Perspective on the Benefits Realized From the FDA's Model‐Informed Drug Development Paired Meeting Pilot Program.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 5, p. 1172, doi. 10.1002/cpt.2265
- By:
- Publication type:
- Article